News Related to IL-17

Related coverage linked through entity extraction aliases.

Novartis pipeline and growth targets remain central to investor focus

Apr 18, 2026

Novartis is emphasizing innovative medicines across oncology, immunology, neuroscience and gene therapy. The company targets mid-single-digit sales growth through 2027 and core operating income margins above 35%.

Experimental topical therapies show potential for diabetic foot ulcers

Apr 04, 2026

Experimental topical therapies for diabetic foot ulcers are showing early promise. Studies described probiotic-based treatments, a medieval antimicrobial mixture and a quercetin-loaded hyaluosome gel with anti-inflammatory and wound-healing effects.